Celularity Days Sales Outstanding from 2010 to 2024

CELU Stock  USD 2.76  0.09  3.16%   
Celularity Days Sales Outstanding yearly trend continues to be comparatively stable with very little volatility. Days Sales Outstanding will likely drop to 107.86 in 2024. From the period from 2010 to 2024, Celularity Days Sales Outstanding quarterly data regression had r-value of  0.65 and coefficient of variation of  37.36. View All Fundamentals
 
Days Sales Outstanding  
First Reported
2010-12-31
Previous Quarter
194.24135962
Current Value
107.86
Quarterly Volatility
39.8817284
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Celularity financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Celularity's main balance sheet or income statement drivers, such as Interest Expense of 2.8 M, Ebit of 17.2 M or Net Income Applicable To Common Shares of 17.1 M, as well as many indicators such as Price To Sales Ratio of 1.84, Dividend Yield of 0.0 or PTB Ratio of 1.13. Celularity financial statements analysis is a perfect complement when working with Celularity Valuation or Volatility modules.
  
Check out the analysis of Celularity Correlation against competitors.
For more information on how to buy Celularity Stock please use our How to Invest in Celularity guide.

Latest Celularity's Days Sales Outstanding Growth Pattern

Below is the plot of the Days Sales Outstanding of Celularity over the last few years. It is Celularity's Days Sales Outstanding historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Celularity's overall financial position and show how it may be relating to other accounts over time.
Days Sales Outstanding10 Years Trend
Slightly volatile
   Days Sales Outstanding   
       Timeline  

Celularity Days Sales Outstanding Regression Statistics

Arithmetic Mean106.76
Geometric Mean101.10
Coefficient Of Variation37.36
Mean Deviation32.62
Median81.49
Standard Deviation39.88
Sample Variance1,591
Range113
R-Value0.65
Mean Square Error989.35
R-Squared0.42
Significance0.01
Slope5.80
Total Sum of Squares22,268

Celularity Days Sales Outstanding History

2024 107.86
2023 194.24
2022 141.45
2021 89.53
2019 167.44

About Celularity Financial Statements

Celularity shareholders use historical fundamental indicators, such as Days Sales Outstanding, to determine how well the company is positioned to perform in the future. Although Celularity investors may analyze each financial statement separately, they are all interrelated. The changes in Celularity's assets and liabilities, for example, are also reflected in the revenues and expenses on on Celularity's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Days Sales Outstanding 194.24  107.86 

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Celularity Stock Analysis

When running Celularity's price analysis, check to measure Celularity's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Celularity is operating at the current time. Most of Celularity's value examination focuses on studying past and present price action to predict the probability of Celularity's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Celularity's price. Additionally, you may evaluate how the addition of Celularity to your portfolios can decrease your overall portfolio volatility.